title: [The cost of cancer in France: macroeconomic and microeconomic approaches, evolution towards a prospective payment system].
abstract: In this article we have reviewed the cost of cancer in France, based on a literature review. The cost of the treatment of cancer is estimated to be 10 thousand million euros for 75,000 lives saved annually. The increasing number of economic evaluations of cancer use both a macro economic approach, based on DRG data, and a micro economic approach, based on cost result analysis. These cost studies provide the elements for a decision aid in the context of social demands, budget constraints and the evolution towards a DRG's prospective payment system which characterises present organisation of health care in France.
authors.affiliation: Gresac, Unité CNRS 5823, Centre Léon-Bérard, 28 rue Laennec, 69373 Lyon, France. perrierl@lyon.fnclcc.fr
authors.forename: Lionel
authors.initials: L
authors.lastname: Perrier
authors.forename: Laurent
authors.initials: L
authors.lastname: Borella
authors.forename: Thierry
authors.initials: T
authors.lastname: Philip
mesh_terms: D003362:Cost-Benefit Analysis; D003953:Diagnosis-Related Groups; D005602:France; D017048:Health Care Costs; D005102:Health Expenditures; D006801:Humans; D009369:Neoplasms / Q000191:economics* / Q000628:therapy